Submit your email to push it up the queue
Pharmaceutical Calibrations & Instrumentation, LLC, commonly referred to as PCI, is a leading provider of calibration and instrumentation services headquartered in the United States. Established in 2005, PCI has made significant strides in the pharmaceutical and biotechnology sectors, focusing on ensuring compliance and accuracy in laboratory environments. With a strong presence across major operational regions in the US, PCI offers a comprehensive range of services, including calibration, validation, and maintenance of laboratory instruments. Their commitment to precision and adherence to industry standards sets them apart in a competitive market. Recognised for their expertise, PCI has achieved notable milestones, including partnerships with prominent pharmaceutical companies. Their dedication to quality and customer satisfaction has solidified their position as a trusted name in pharmaceutical calibrations and instrumentation.
How does Pharmaceutical Calibrations & Instrumentation, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Calibrations & Instrumentation, LLC's score of 41 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Calibrations & Instrumentation, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Applied Industrial Technologies, Inc., which may influence its climate commitments and reporting practices. As of now, there are no documented reduction targets or climate pledges from Pharmaceutical Calibrations & Instrumentation, LLC. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of direct emissions data and reduction initiatives, it is essential for Pharmaceutical Calibrations & Instrumentation, LLC to consider establishing measurable climate commitments and targets in line with industry standards. This could enhance their sustainability profile and align them with broader corporate responsibility trends within the pharmaceutical and instrumentation sectors.
Access structured emissions data, company-specific emission factors, and source documents
2023 | 2024 | |
---|---|---|
Scope 1 | 32,600,000 | 00,000,000 |
Scope 2 | 15,400,000 | 00,000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutical Calibrations & Instrumentation, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.